Dostarlimab (Anti-PDCD1 / PD-1 / CD279)
Product Specifications
CAS Number
2022215-59-2
SKU
C00594-1mg
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Dostarlimab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 ((PD-1 programmed death-1), with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.18 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1059946-01 0.02 mg (E-Coli)
Recombinant Sicarius cf. damarensis Sphingomyelin phosphodiesterase D SdSicTox-betaIIB2i
Ask
View Details MBS1059946-02 0.02 mg (Yeast)
Recombinant Sicarius cf. damarensis Sphingomyelin phosphodiesterase D SdSicTox-betaIIB2i
Ask
View Details MBS1059946-03 0.1 mg (E-Coli)
Recombinant Sicarius cf. damarensis Sphingomyelin phosphodiesterase D SdSicTox-betaIIB2i
Ask
View Details MBS1059946-04 0.1 mg (Yeast)
Recombinant Sicarius cf. damarensis Sphingomyelin phosphodiesterase D SdSicTox-betaIIB2i
Ask
View Details 
MBS1059946-05 0.02 mg (Baculovirus)
Recombinant Sicarius cf. damarensis Sphingomyelin phosphodiesterase D SdSicTox-betaIIB2i
Ask
View Details